Lunai Bioworks Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Lunai Bioworks Inc. (LNAI) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$226.20 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-11-20
- Lunai Bioworks Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$226.20K.
- Lunai Bioworks Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$196.14K, a 118.63% decline from fiscal 2016.
- Lunai Bioworks Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $1.05M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|
| 2017-09-30 | -$226.20K 10-Q · filed 2017-11-20 | |
| 2017-06-30 | -$196.14K 10-K · filed 2017-11-20 | |
| 2016-06-30 | $1.05M 10-K · filed 2017-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |